Vacirca Jeff L bought CAI

May 11, 2026 · Form 4 insider transaction

Vacirca Jeff L bought 31,050 shares of Caris Life Sciences, Inc. at $16.15 per share, a transaction worth $501.4K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
31,050
Price
$16.15
Total value
$501.4K
Role
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 11, 2026
Filing dateMay 12, 2026
Shares owned after49,671
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.13 to $16.15, inclusive. The reporting person undertakes to provide to Caris Life Sciences, Inc., any security holder of Caris Life Sciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote

View the original Form 4 on SEC EDGAR